Fujifilm Holdings Corp. reported a significant drop in its first-quarter net profit for the fiscal year 2026, falling 30.4% to ¥37.4 billion. This decline, announced on August 6, followed a year-over-year revenue increase of 10.3% to ¥826.5 billion, which was a record high for a first quarter. The company attributed the profit decline to several factors, including higher fixed costs in its Bio CDMO business, one-time restructuring costs in the Business Innovation segment, and rising raw material prices. Operating income also saw a substantial decrease of 32.0% to ¥51.2 billion.
Despite the record Q1 revenue driven by strong sales in the Healthcare and Electronics segments, Fujifilm revised its full-year revenue guidance downwards. The new forecast for the fiscal year 2026 is ¥3,560.0 billion, a reduction from the previous projection, though operating income and net income attributable to FUJIFILM Holdings remain unchanged at ¥365.0 billion and ¥280.0 billion respectively. The company noted that the revenue revision reflects strong sales in the Electronics segments and favorable exchange rates, but profit growth in Electronics is offset by delays in the Bio CDMO business.
For the fiscal year ended March 31, 2026, Fujifilm Holdings reported consolidated revenue of ¥276.7 billion, an increase of 6.1% year-over-year. The impact of the 2026 Kumamoto Earthquake was assessed as limited, with operations gradually resuming from August 2. However, the disappointing first-quarter profit figures and the revised revenue outlook led to a significant drop in Fujifilm's share price.
